Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doms

Showing results (331-340 of 335) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 335 results.
Plos Pathogens|June 14, 2012
Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7Nicholas F Parrish, Craig B Wilen, Lauren B Banks, et al.
The Journal of Experimental Medicine|November 22, 2022
Intelectin-1 binds and alters the localization of the mucus barrier-modifying bacterium Akkermansia muciniphilaJuan D Matute, Jinzhi Duan, Magdalena B Flak, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2013
Phenotypic properties of transmitted founder HIV-1Nicholas F Parrish, Feng Gao, Hui Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2016
Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaquesHui Li, Shuyi Wang, Rui Kong, et al.
Science (New York, N.Y.)|October 26, 2006
A plea for justice for jailed medical workersSunil K Ahuja, Fernando Aiuti, Ben Berkhout, et al.
Pageof 34

Showing results (331-340 of 335) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 335 results.
Plos Pathogens|June 14, 2012
Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7Nicholas F Parrish, Craig B Wilen, Lauren B Banks, et al.
The Journal of Experimental Medicine|November 22, 2022
Intelectin-1 binds and alters the localization of the mucus barrier-modifying bacterium Akkermansia muciniphilaJuan D Matute, Jinzhi Duan, Magdalena B Flak, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2013
Phenotypic properties of transmitted founder HIV-1Nicholas F Parrish, Feng Gao, Hui Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2016
Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaquesHui Li, Shuyi Wang, Rui Kong, et al.
Science (New York, N.Y.)|October 26, 2006
A plea for justice for jailed medical workersSunil K Ahuja, Fernando Aiuti, Ben Berkhout, et al.
Pageof 34